Demographic Characteristics and Transmission Risk Factors of Patients with Hepatitis C Virus in Turkey: The EPI-C, A Multicenter and Cross-sectional Trial

dc.authorid0000-0003-4518-5283
dc.authorid0000-0002-4563-7027
dc.authorid0000-0002-8772-0769
dc.authorid0000-0001-8632-2825
dc.authorid0000-0002-6945-3193
dc.authorid0000-0003-3508-7516
dc.authorid0000-0002-2263-6689
dc.contributor.authorTabak, Fehmi
dc.contributor.authorSirin, Goktug
dc.contributor.authorDemir, Mehmet
dc.contributor.authorAladag, Murat
dc.contributor.authorSumer, Sua
dc.contributor.authorKurtaran, Behice
dc.contributor.authorTosun, Selma
dc.date.accessioned2025-05-10T19:53:12Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjectives: To describe the prevalence of risk factors in patients infected with hepatitis C virus (HCV). Materials and Methods: Patients who were aged >18 years visiting outpatient clinics and diagnosed as having HCV infection were enrolled in this cross-sectional, multicenter study conducted in 71 cities. Patient data on socio-demographic and clinical characteristics and pre-defined risk factors were collected. Results: Among 1,018 patients, 53.0% were women. The mean age was 57.2 +/- 14.3 years and 34.8% had been diagnosed as having HCV infection >10 years before enrollment. Almost half of the patients (45.5%) were diagnosed during their regular check-up visits, and only 16.8% were diagnosed because of signs or symptoms of HCV. Genotype 1 and sub-genotype 1 b were detected in 87.9% and 73.7% of the patients, respectively. At least one risk factor was present in 94.8% of the patients. The most frequently reported risk factor was major dental procedures (79.2%), followed by major surgical operations (56.9%) and minor surgical interventions (42.3%). Conclusion: Our results revealed that most of the patients with HCV infection underwent major dental procedures.
dc.description.sponsorshipAbbVie Inc. (North Chicago, IL, USA); AbbVie
dc.description.sponsorshipThis study was funded in full by AbbVie Inc. (North Chicago, IL, USA). Statistical analysis, writing support, and editing services in the development of this manuscript were provided by MONITOR CRO (Istanbul, Turkey) and funded by AbbVie. The authors also acknowledge the other participants of the EPI-C Study (protocol number 10-989) Team.
dc.identifier.doi10.4274/vhd.galenos.2021.2021-1-3
dc.identifier.endpage117
dc.identifier.issn1307-9441
dc.identifier.issn2147-2939
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85208514093
dc.identifier.scopusqualityN/A
dc.identifier.startpage109
dc.identifier.trdizinid507561
dc.identifier.urihttps://doi.org/10.4274/vhd.galenos.2021.2021-1-3
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/507561
dc.identifier.urihttps://hdl.handle.net/20.500.14730/12671
dc.identifier.volume27
dc.identifier.wosWOS:000735716400001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherGalenos Yayincilik
dc.relation.ispartofViral Hepatit Dergisi-Viral Hepatitis Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectHepatitis C
dc.subjectdemography
dc.subjectrisk factors
dc.subjectTurkey
dc.titleDemographic Characteristics and Transmission Risk Factors of Patients with Hepatitis C Virus in Turkey: The EPI-C, A Multicenter and Cross-sectional Trial
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
12671.pdf
Boyut:
286.74 KB
Biçim:
Adobe Portable Document Format